Company KAINOS Laboratories, Inc.

Equities

4556

JP3205650009

Medical Equipment, Supplies & Distribution

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sales per Business

Sector Diagnostic & Testing Substances

Delayed Japan Exchange Other stock markets 01:59:30 2024-04-23 am EDT			5-day change	1st Jan Change
1,204 ^JPY	+1.01%		-0.41%	+10.36%

2022	KAINOS Laboratories, Inc. announced that it has received ¥250.47 million in funding from Sysmex Corporation	CI
2022	KAINOS Laboratories, Inc. announced that it expects to receive ¥250.47 million in funding from Sysmex Corporation	CI

KAINOS Laboratories, Inc. is pricipally engaged in researching, developing, manufacturing and selling clinical diagnostic reagents, including biochemical diagnostic reagents such as renal function related reagents and automatic biochemical analytical reagents, immune serological test reagents such as transfusion-related reagents, allergy-related reagents, cancer marker related reagents, and other reagents.

Number of employees: 133

JPY in Million	2022	Weight	2023	Weight	Delta
Biochemical Test Reagent 48.0 %	2,303	49.9 %	2,361	48.0 %	+2.52%
ImmunoserumTest Reagent 45.7 %	2,095	45.4 %	2,248	45.7 %	+7.27%
Other 6.4 %	216	4.7 %	314	6.4 %	+45.30%

JPY in Million	2022	Weight	2023	Weight	Delta
Japan 100.0 %	4,615	100.0 %	4,923	100.0 %	+6.69%

Managers	Title	Age	Since
Yukihiro Nagatsu PSD	President	64	82-03-31
Akihiko Suga CTO	Chief Tech/Sci/R&D Officer	-	-
Sumio Shirai CMP	Compliance Officer	-	-
Tsukasa Hayashi ADM	Chief Administrative Officer	62	93-09-30
Shigeo Kobayashi AUD	Comptroller/Controller/Auditor	69	78-03-31

Members of the board	Title	Age	Since
Nobuo Nakano BRD	Director/Board Member	70	-
Yukihiro Nagatsu PSD	President	64	82-03-31
Tsukasa Hayashi ADM	Chief Administrative Officer	62	93-09-30
Kazumasa Otsubo BRD	Director/Board Member	63	14-05-31
Kenji Kikuchi BRD	Director/Board Member	72	14-05-31
Fumitomo Odawara BRD	Director/Board Member	59	19-05-31
Kunihiko Koga BRD	Director/Board Member	59	19-05-31
Mitsuhisa Kanagawa BRD	Director/Board Member	-	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	0	4,558,860	1,756,860 ( 38.54 %)	343,200 ( 7.528 %)	38.54 %

Name	Equities	%	Valuation
ASAHI KASEI CORPORATION 20.62 %	940,000	20.62 %	7 M ¥
HIKARI TSUSHIN, INC. 11.76 %	536,000	11.76 %	4 M ¥
Akiko Sugiyama 9.761 %	445,000	9.761 %	4 M ¥
SYSMEX CORPORATION 5.045 %	230,000	5.045 %	2 M ¥
Kainos Laboratories Employee Stock Ownership Plan 3.992 %	182,000	3.992 %	1 M ¥
Kainos Laboratories Employee Incentive Plan 3.933 %	179,300	3.933 %	1 M ¥
KAINOS LABORATORIES, INC. 2.406 %	109,700	2.406 %	867 626 ¥
Kainos Laboratories Board Benefit Trust 2.101 %	95,800	2.101 %	757 690 ¥
SIL KK 1.334 %	60,800	1.334 %	480 872 ¥
NIPPON KAYAKU CO., LTD. 1.097 %	50,000	1.097 %	395 454 ¥

Name	Equities	%	Valuation
KAINOS LABORATORIES, INC. 2.41%	109,700	2.41%	867,626 $
MIZUHO FINANCIAL GROUP, INC. 0.00%	36,419	0.00%	732,976 $
NIPPON KAYAKU CO., LTD. 0.03%	49,000	0.03%	422,835 $
TOHOKU CHEMICAL CO., LTD. 0.10%	1,000	0.10%	26,496 $
RESONA HOLDINGS, INC. 0.00%	4,000	0.00%	25,116 $
ASAHI KASEI CORPORATION 0.00%	3,000	0.00%	22,042 $
HOKUYAKU TAKEYAMA HOLDINGS,INC. 0.01%	3,000	0.01%	17,245 $

Kainos Laboratories, Inc.

2-38-18 Hongo Bunkyo-Ku

113-0033, Tokyo

http://www.kainos.co.jp

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Diagnostic & Testing Substances

	1st Jan change	Capi.
KAINOS LABORATORIES, INC.	+10.36%	34.27M
BIOMÉRIEUX	+0.99%	12.66B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-17.03%	7.04B
LANTHEUS HOLDINGS, INC.	+1.73%	4.32B
AUTOBIO DIAGNOSTICS CO., LTD.	-2.51%	4.45B
10X GENOMICS, INC.	-50.32%	3.31B
ANDON HEALTH CO., LTD.	+6.90%	2.6B
VITROLIFE AB	-16.18%	2.01B
MYRIAD GENETICS, INC.	-3.40%	1.67B
SANSURE BIOTECH INC.	-6.24%	1.45B

Diagnostic & Testing Substances